Trump to reveal new drug price deals

U.S. President Donald Trump announced new agreements with pharmaceutical companies to reduce drug prices in the United States, aiming to make medications more affordable and lower costs for patients. This step follows previous agreements with 17 major pharmaceutical companies, in which these companies agreed to provide drugs at lower prices aligned with those in developed countries and to reduce prices for certain medications involved in federal healthcare programs. However, smaller pharmaceutical companies are lagging behind in joining these efforts. It is expected that these initiatives will save approximately $64.3 billion over ten years, although the actual amount of savings remains uncertain. The goal of these measures is to cut healthcare costs in America, which are high compared to what patients pay in other countries.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل